← All startups
Colossal logo

Colossal

Colossal is a breakthrough bioscience and genetic engineering company that builds radical new technologies to advance the field of genomics. Colossal creates disruptive technologies for extinct species restoration, critically endangered species protection and the repopulation of critical ecosystems that support the continuation of life on Earth. The company is the first to apply CRISPR technology for the purposes of species de-extinction.

Dallas20 people
Latest round$120.0M · VentureSep 18, 2025
Listed Sep 2025Biotech

Team20

NameLocationLinksContact
Adam Milne
COO
Cambridge, Massachusetts, United States
—
Andrew Busey
Co-Founder
Austin, Texas, United States
—
Ben Lamm
Founder
Dallas, Texas, United States
—
Beth Shapiro
Chief Science Officer
Santa Cruz, California, United States
—
George Church
Co-Founder
Boston, Massachusetts, United States
—
Matt James
Chief Animal Officer
Dallas, Texas, United States
—
Sam Singer
CFO
Boston, Massachusetts, United States
—
Chris Klee
Executive Vice President Of Marketing
Breckenridge, Colorado, United States
—
Ana V.
Associate Director of Genome Engineering
New York City Metropolitan Area
—
Cheryl Noga
Director
Philadelphia, Pennsylvania, United States
—
David Brooks
Head Of Content Production
Los Angeles, California, United States
—
Sarah Grant
Chief of Staff
Austin, Texas, United States
—
Yi-Hsien Chen
Director Of Cell
Seattle, Washington, United States
—
Cori N. Booker
Manager
Dallas-Fort Worth Metroplex
—
Hao Bai
Manager
Waltham, Massachusetts, United States
—
Martin Nicholson
Manager
United States
—
Nick Matinyan
Manager
Dallas, Texas, United States
—
Austin Gallagher
Advisory Board Member
Boston, Massachusetts, United States
—
David Spirk
Advisory Board Member
—
—
Mark N. Fox
Chairman
—
—
Join Discord